The gynecomastia treatment market size has grown strongly in recent years. It will grow from $2.98 billion in 2025 to $3.23 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing diagnosis rates of gynecomastia, growing awareness of male health conditions, availability of advanced surgical procedures, expansion of aesthetic medicine services, rising acceptance of corrective treatments.
The gynecomastia treatment market size is expected to see strong growth in the next few years. It will grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized treatment plans, rising adoption of advanced liposuction technologies, expansion of outpatient surgical facilities, growing focus on psychological well-being, increasing investment in male health services. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising demand for hormone-based medical therapies, growing preference for combined treatment approaches, expansion of specialized aesthetic clinics, enhanced focus on patient counseling and post-treatment care.
The increasing acceptance of male aesthetic and cosmetic procedures is expected to stimulate the growth of the gynecomastia treatment market in the future. Male aesthetic and cosmetic procedures include medical and surgical treatments aimed at enhancing physical appearance, addressing areas such as body contouring, facial aesthetics, skin quality, and hair restoration. Acceptance of these procedures is rising due to evolving societal attitudes toward male grooming and body image, influenced by media exposure and increased awareness of aesthetic treatment options. Greater participation in male aesthetic and cosmetic procedures has encouraged men to seek gynecomastia treatment to achieve a firmer and more masculine chest profile. For example, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based professional organization, men accounted for 6% of all cosmetic procedures performed in 2023, with male body-focused procedures increasing by 18% and face and neck procedures rising by 15% compared to the previous year. Therefore, the increasing acceptance of male aesthetic and cosmetic procedures is supporting the growth of the gynecomastia treatment market.
The rising healthcare expenditure is expected to propel the growth of the gynecomastia treatment market going forward. Healthcare expenditure refers to the total financial resources spent on medical services, preventive care, medications, infrastructure, and related health activities to maintain or improve population health. Healthcare expenditure is increasing due to the rising prevalence of chronic and infectious diseases, which fuels sustained demand for long-term care, advanced therapies, and continuous medical services. Higher healthcare spending improves affordability and accessibility of elective procedures, enabling more men to pursue gynecomastia treatment to enhance chest appearance. For example, in April 2025, according to the Office for National Statistics, a UK-based government organization, overall healthcare spending rose by 6.5% from 2023 to 2024, marking faster growth compared with 2023 levels. Therefore, the rising healthcare expenditure is driving the growth of the gynecomastia treatment market.
In December 2024, Lorena Cosmetics Holdings SPV Limited, a UK-based healthcare services company, acquired the Harley Medical Group for an undisclosed amount. Through this acquisition, Lorena Cosmetics aimed to revitalize and consolidate an established cosmetic surgery brand, expand its presence within the UK aesthetic and surgical services sector, and strengthen its vertically integrated healthcare portfolio following the company’s administration process. The Harley Medical Group is a UK-based provider specializing in cosmetic procedures including gynecomastia surgery.
Major companies operating in the gynecomastia treatment market are Spire Healthcare Group Plc, Max Healthcare Institute, InMode Ltd., Cynosure Inc., Pristyn Care Private Limited, Sterling Hospital, Paras Hospital, Prettislim Clinic, Allure Medspa, Lux Hospitals, Florida Plastic Surgery Group, Dermawear, DermaVue, AK Clinics Pvt. Ltd., BioZen, Medifyhome, PinkApple Aesthetics, The Aesthetica, Austin Gynecomastia Center, and Carely Clinic.
Tariffs are influencing the gynecomastia treatment market by increasing costs of imported surgical instruments, liposuction devices, hormone therapy drugs, and medical consumables used in treatment procedures. Healthcare providers in North America and Europe are most affected due to reliance on imported medical equipment and pharmaceuticals, while Asia-Pacific faces cost pressures in device manufacturing and distribution. These tariffs are contributing to higher treatment costs and influencing service pricing. At the same time, they are supporting domestic medical device production, regional pharmaceutical manufacturing, and innovation in cost-effective treatment solutions.
The gynecomastia treatment market research report is one of a series of new reports that provides gynecomastia treatment market statistics, including gynecomastia treatment industry global market size, regional shares, competitors with a gynecomastia treatment market share, detailed gynecomastia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gynecomastia treatment industry. This gynecomastia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gynecomastia treatment is a focused medical and surgical strategy aimed at diagnosing, managing, and correcting gynecomastia, a condition marked by benign enlargement of male breast tissue caused by hormonal imbalances, medications, or underlying health issues. The treatment seeks to reduce excess glandular or fatty tissue, restore a normal chest contour, relieve physical discomfort, and enhance psychological well-being through medical therapy, minimally invasive procedures, or surgical interventions.
The primary types of gynecomastia treatment include medications, surgical treatments, and alternative therapies. Medications refer to pharmaceutical interventions used to address hormonal imbalances or underlying causes of gynecomastia. These treatments are applied across age groups including adolescents, adults, and middle-aged and older populations. Distribution occurs via direct sales, distributor sales, and online platforms, and end users include hospitals, aesthetic clinics, ambulatory surgical centers, and endocrinology clinics.
The gynecomastia treatment market consists of revenues earned by entities by providing services such as surgical evaluation and procedures, post-operative care and follow-up, counseling on lifestyle modifications, and non-surgical management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gynecomastia treatment market also includes sales of liposuction devices, hormone therapy drugs, topical treatments, and other supportive medical devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The gynecomastia treatment market size is expected to see strong growth in the next few years. It will grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized treatment plans, rising adoption of advanced liposuction technologies, expansion of outpatient surgical facilities, growing focus on psychological well-being, increasing investment in male health services. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising demand for hormone-based medical therapies, growing preference for combined treatment approaches, expansion of specialized aesthetic clinics, enhanced focus on patient counseling and post-treatment care.
The increasing acceptance of male aesthetic and cosmetic procedures is expected to stimulate the growth of the gynecomastia treatment market in the future. Male aesthetic and cosmetic procedures include medical and surgical treatments aimed at enhancing physical appearance, addressing areas such as body contouring, facial aesthetics, skin quality, and hair restoration. Acceptance of these procedures is rising due to evolving societal attitudes toward male grooming and body image, influenced by media exposure and increased awareness of aesthetic treatment options. Greater participation in male aesthetic and cosmetic procedures has encouraged men to seek gynecomastia treatment to achieve a firmer and more masculine chest profile. For example, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based professional organization, men accounted for 6% of all cosmetic procedures performed in 2023, with male body-focused procedures increasing by 18% and face and neck procedures rising by 15% compared to the previous year. Therefore, the increasing acceptance of male aesthetic and cosmetic procedures is supporting the growth of the gynecomastia treatment market.
The rising healthcare expenditure is expected to propel the growth of the gynecomastia treatment market going forward. Healthcare expenditure refers to the total financial resources spent on medical services, preventive care, medications, infrastructure, and related health activities to maintain or improve population health. Healthcare expenditure is increasing due to the rising prevalence of chronic and infectious diseases, which fuels sustained demand for long-term care, advanced therapies, and continuous medical services. Higher healthcare spending improves affordability and accessibility of elective procedures, enabling more men to pursue gynecomastia treatment to enhance chest appearance. For example, in April 2025, according to the Office for National Statistics, a UK-based government organization, overall healthcare spending rose by 6.5% from 2023 to 2024, marking faster growth compared with 2023 levels. Therefore, the rising healthcare expenditure is driving the growth of the gynecomastia treatment market.
In December 2024, Lorena Cosmetics Holdings SPV Limited, a UK-based healthcare services company, acquired the Harley Medical Group for an undisclosed amount. Through this acquisition, Lorena Cosmetics aimed to revitalize and consolidate an established cosmetic surgery brand, expand its presence within the UK aesthetic and surgical services sector, and strengthen its vertically integrated healthcare portfolio following the company’s administration process. The Harley Medical Group is a UK-based provider specializing in cosmetic procedures including gynecomastia surgery.
Major companies operating in the gynecomastia treatment market are Spire Healthcare Group Plc, Max Healthcare Institute, InMode Ltd., Cynosure Inc., Pristyn Care Private Limited, Sterling Hospital, Paras Hospital, Prettislim Clinic, Allure Medspa, Lux Hospitals, Florida Plastic Surgery Group, Dermawear, DermaVue, AK Clinics Pvt. Ltd., BioZen, Medifyhome, PinkApple Aesthetics, The Aesthetica, Austin Gynecomastia Center, and Carely Clinic.
Tariffs are influencing the gynecomastia treatment market by increasing costs of imported surgical instruments, liposuction devices, hormone therapy drugs, and medical consumables used in treatment procedures. Healthcare providers in North America and Europe are most affected due to reliance on imported medical equipment and pharmaceuticals, while Asia-Pacific faces cost pressures in device manufacturing and distribution. These tariffs are contributing to higher treatment costs and influencing service pricing. At the same time, they are supporting domestic medical device production, regional pharmaceutical manufacturing, and innovation in cost-effective treatment solutions.
The gynecomastia treatment market research report is one of a series of new reports that provides gynecomastia treatment market statistics, including gynecomastia treatment industry global market size, regional shares, competitors with a gynecomastia treatment market share, detailed gynecomastia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gynecomastia treatment industry. This gynecomastia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gynecomastia treatment is a focused medical and surgical strategy aimed at diagnosing, managing, and correcting gynecomastia, a condition marked by benign enlargement of male breast tissue caused by hormonal imbalances, medications, or underlying health issues. The treatment seeks to reduce excess glandular or fatty tissue, restore a normal chest contour, relieve physical discomfort, and enhance psychological well-being through medical therapy, minimally invasive procedures, or surgical interventions.
The primary types of gynecomastia treatment include medications, surgical treatments, and alternative therapies. Medications refer to pharmaceutical interventions used to address hormonal imbalances or underlying causes of gynecomastia. These treatments are applied across age groups including adolescents, adults, and middle-aged and older populations. Distribution occurs via direct sales, distributor sales, and online platforms, and end users include hospitals, aesthetic clinics, ambulatory surgical centers, and endocrinology clinics.
The gynecomastia treatment market consists of revenues earned by entities by providing services such as surgical evaluation and procedures, post-operative care and follow-up, counseling on lifestyle modifications, and non-surgical management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gynecomastia treatment market also includes sales of liposuction devices, hormone therapy drugs, topical treatments, and other supportive medical devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Gynecomastia Treatment Market Characteristics
3. Gynecomastia Treatment Market Supply Chain Analysis
4. Global Gynecomastia Treatment Market Trends and Strategies
5. Gynecomastia Treatment Market Analysis Of End Use Industries
7. Global Gynecomastia Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Gynecomastia Treatment Total Addressable Market (TAM) Analysis for the Market
9. Gynecomastia Treatment Market Segmentation
10. Gynecomastia Treatment Market Regional and Country Analysis
11. Asia-Pacific Gynecomastia Treatment Market
12. China Gynecomastia Treatment Market
13. India Gynecomastia Treatment Market
14. Japan Gynecomastia Treatment Market
15. Australia Gynecomastia Treatment Market
16. Indonesia Gynecomastia Treatment Market
17. South Korea Gynecomastia Treatment Market
18. Taiwan Gynecomastia Treatment Market
19. South East Asia Gynecomastia Treatment Market
20. Western Europe Gynecomastia Treatment Market
21. UK Gynecomastia Treatment Market
22. Germany Gynecomastia Treatment Market
23. France Gynecomastia Treatment Market
24. Italy Gynecomastia Treatment Market
25. Spain Gynecomastia Treatment Market
26. Eastern Europe Gynecomastia Treatment Market
27. Russia Gynecomastia Treatment Market
28. North America Gynecomastia Treatment Market
29. USA Gynecomastia Treatment Market
30. Canada Gynecomastia Treatment Market
31. South America Gynecomastia Treatment Market
32. Brazil Gynecomastia Treatment Market
33. Middle East Gynecomastia Treatment Market
34. Africa Gynecomastia Treatment Market
36. Gynecomastia Treatment Market Competitive Landscape and Company Profiles
37. Gynecomastia Treatment Market Other Major and Innovative Companies
41. Gynecomastia Treatment Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Gynecomastia Treatment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses gynecomastia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for gynecomastia treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gynecomastia treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Treatment Type: Medications; Surgical Treatments; Alternative Therapies2) By Age Group: Adolescents; Adults; Middle Aged and Older
3) By Distribution Channel: Direct Sales; Distributor Sales; Online Sales
4) By End User: Hospitals; Aesthetic Clinics; Ambulatory Surgical Centers; Endocrinology Clinics
Subsegments:
1) By Medications: Hormone Regulating Drug Therapies; Estrogen Blocking Drug Therapies; Testosterone Modulating Drug Therapies2) By Surgical Treatments: Liposuction Based Breast Reduction Procedures; Glandular Tissue Excision Procedures; Combined Liposuction and Excision Procedures
3) By Alternative Therapies: Lifestyle and Weight Management Programs; Dietary and Nutritional Support Therapies; Herbal and Natural Supplement Therapies
Companies Mentioned: Spire Healthcare Group Plc; Max Healthcare Institute; InMode Ltd.; Cynosure Inc.; Pristyn Care Private Limited; Sterling Hospital; Paras Hospital; Prettislim Clinic; Allure Medspa; Lux Hospitals; Florida Plastic Surgery Group; Dermawear; DermaVue; AK Clinics Pvt. Ltd.; BioZen; Medifyhome; PinkApple Aesthetics; The Aesthetica; Austin Gynecomastia Center; and Carely Clinic.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Gynecomastia Treatment market report include:- Spire Healthcare Group Plc
- Max Healthcare Institute
- InMode Ltd.
- Cynosure Inc.
- Pristyn Care Private Limited
- Sterling Hospital
- Paras Hospital
- Prettislim Clinic
- Allure Medspa
- Lux Hospitals
- Florida Plastic Surgery Group
- Dermawear
- DermaVue
- AK Clinics Pvt. Ltd.
- BioZen
- Medifyhome
- PinkApple Aesthetics
- The Aesthetica
- Austin Gynecomastia Center
- and Carely Clinic.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | March 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.23 Billion |
| Forecasted Market Value ( USD | $ 4.49 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
